Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)
Host: Kara B. Markham, MD
\n\n\n \n
What are the essential steps in managing hemolytic disease of the fetus and newborn (HDFN)? How soon after \u201cthe cord has been cut\u201d does newborn care transfer from the maternal-fetal medicine specialist and ob-gyn to the pediatric team? At a recent satellite symposium of the American Academy of Pediatrics, Dr. James Bussel, Dr. Kara Markham, and Bethany Weathersby presented the latest data regarding current and emerging practice patterns and highlighted the critical need for improved understanding and multidisciplinary collaboration in the area of HDFN. Tune in to hear Dr. Markham summarize how diagnosis, care, and treatment have evolved\u2014plus insights on how these might change the way you practice.